Home » Alzheimers » editorsBio.php Alzheimers & Parkinsons Disease: Open Access


Amit Kumar

Amit Kumar

Weill Medical College of Cornell University, USA

Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.